Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Abacus Global Management, Inc. (NASDAQ: ABL) Under Investigation Following “Fake Revenue” Allegations; Investors Urged to Contact Award-Winning Firm, Gibbs Mura

Shares of Abacus Global Management, Inc. (“Abacus”) fell over 30% in intraday trading on Wednesday, June 4, 2025, after Morpheus Research published an article alleging that the financial services company is a “life settlements accounting scheme manufacturing fake revenue by systematically underestimating when people will die.” Gibbs Mura is investigating a potential Abacus Global Management, Inc. (NASDAQ: ABL) Securities Class Action Lawsuit on behalf of shareholders who lost money in Abacus.

What Should Abacus Global Management, Inc. Investors Do?

If you invested in ABL, visit our Abacus Global Management, Inc. investigation webpage, or call us at (888) 410-2925 to get more information about how you may be able to recover your losses. Our investigation concerns whether Abacus has violated federal securities laws by providing false or misleading statements to investors.

What is the Abacus Global Management, Inc. (ABL) Lawsuit Investigation About?

On June 4, 2025, Morpheus Research published a detailed report alleging that Abacus is a “life settlements accounting scheme manufacturing fake revenue by systematically underestimating when people will die.”

Morpheus’s three-month investigation into Abacus, which purportedly included expert interviews, review of corporate records and court documents, and discussions with former Abacus employees, allegedly uncovered that Abacus’s returns are “primarily manufactured by the systematic overvaluation of its assets through an opaque ‘mark to model’ accounting scheme that closely mirrors past blow-ups in the life settlements industry.”

The report claims that Abacus “has resorted to slashing its discount rate to generate more non-cash gains,” a tactic that has been linked to other notorious life settlement frauds such as GWG Holdings.

Following this news, shares of Abacus Global Management, Inc. plummeted over 30% in intraday trading on June 4, 2025, causing significant harm to investors.

About Gibbs Mura, A Law Group

Gibbs Mura represents investors nationwide in securities litigation to correct abusive corporate governance practices, breaches of fiduciary duty, and proxy violations. The firm has recovered over a billion dollars for its clients against some of the world’s largest corporations, and our attorneys have received numerous honors for their work, including “Best Lawyers in America,” “Top Plaintiff Lawyers in California,” “California Lawyer Attorney of the Year,” “Class Action Practice Group of the Year,” “Consumer Protection MVP,” and “Top Women Lawyers in California.”

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

On June 4, 2025, Morpheus Research published a detailed report alleging that Abacus is a “life settlements accounting scheme manufacturing fake revenue by systematically underestimating when people will die.”

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.